Management of Postoperative Pain With Preemptive Analgesia in Cesarean Section
Status unconfirmed · Not applicable · Has a placebo group
Conditions studied: Labor Pain
In brief
This research will explore the question of whether preincisional skin infiltration with bupivacaine 0.25% decreases postoperative pain after Cesarean delivery.
Key facts
- Study ID
- NCT02879435
- Run by
- Mark Kosanovich
- People needed
- 120
- Starts
- 2016-06-01
- Expected to finish
- 2017-03-01
- Last updated by the study team
- 2016-08-25
Who can join
Age: 18 and older, up to 45. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- adult pregnant women to age 45 with scheduled cesarean sections at Mercy Hospital and Medical Center
You may not qualify if…
- Emergent cesarean sections and subjects with contraindications to bupivacaine
Where it is running
- Mercy Hospital & Medical Center — Chicago, Illinois, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.